main-logo

ICD-10 Code C44.619 | Basal cell carcinoma skin/ left upper limb, inc shoulder Symptoms, Diagnosis, Billing

Basal cell carcinoma (BCC) is a common skin cancer originating from basal cells in the epidermis. It is primarily caused by prolonged exposure to ultraviolet (UV) radiation. Clinically significant due to its potential for local invasion and destruction of surrounding tissues, BCC rarely metastasizes. Accurate coding with ICD-10 Code C44.619 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.

What is ICD-10 Code C44.619 for Basal cell carcinoma skin/ left upper limb, inc shoulder?

ICD-10 Code C44.619 specifically denotes basal cell carcinoma located on the skin of the left upper limb, including the shoulder. This code is utilized when documenting cases of BCC that are localized to this anatomical region, ensuring accurate representation of the patient's condition for clinical documentation and billing purposes.

ICD-10 Code C44.619 – Clinical Definition and Explanation of Basal cell carcinoma skin/ left upper limb, inc shoulder

Basal cell carcinoma is primarily caused by UV radiation exposure, leading to mutations in skin cells. It typically presents as a pearly or waxy bump and can progress locally if untreated, necessitating medical intervention. Early detection and treatment are crucial to prevent complications.

Key Clinical Features:

  • Pearly or waxy nodules on the skin
  • Ulceration or bleeding at the site
  • Slow growth over time
  • Commonly occurs in sun-exposed areas

ICD-10 Code C44.619 for Basal cell carcinoma skin/ left upper limb, inc shoulder – SOAP Notes & Clinical Use

ICD-10 Code C44.619 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code C44.619 for Basal cell carcinoma skin/ left upper limb, inc shoulder Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C44.619 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of basal cell carcinoma. This linkage is essential for continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C44.619 – Basal cell carcinoma skin/ left upper limb, inc shoulder

Timely treatment of basal cell carcinoma is crucial to prevent local invasion and complications. Surgical excision is the primary treatment modality.

Antibiotic Therapy:

  • Not applicable as BCC is not infectious.

Supportive Care:

  • Regular follow-up for monitoring
  • Skin protection measures to prevent UV exposure
  • Education on signs of recurrence

Infection Control:

  • Maintain sterile technique during procedures
  • Educate patients on wound care post-surgery

How to Document Symptoms of Basal cell carcinoma skin/ left upper limb, inc shoulder (ICD-10 C44.619) in SOAP Notes

Subjective:

  • Patient reports a new growth on the left shoulder.
  • Describes the lesion as itchy and occasionally bleeding.
  • History of sun exposure and previous skin cancers.

Objective:

  • Physical examination reveals a pearly nodule on the left shoulder.
  • No lymphadenopathy noted.
  • Dermatoscopic examination shows typical features of BCC.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Basal cell carcinoma skin/ left upper limb, inc shoulder (ICD-10 Code C44.619)

Assessment:

  • Diagnosis: Basal cell carcinoma, left upper limb, inc shoulder, localized.
  • ICD-10 Code: C44.619.
  • Contributing factors: History of UV exposure.

Plan:

  • Refer for surgical excision of the lesion.
  • Educate patient on sun protection strategies.
  • Schedule follow-up in 6 months for monitoring.

Treatment & Plan Section for ICD-10 Code C44.619 – Basal cell carcinoma skin/ left upper limb, inc shoulder

  • Surgical excision is the primary treatment.
  • Consider Mohs micrographic surgery for high-risk lesions.
  • Patient education on skin care and UV protection.
  • Regular dermatological follow-ups for surveillance.

Using ICD-10 Code C44.619 for Basal cell carcinoma skin/ left upper limb, inc shoulder in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and findings in SOAP notes.
  • Use C44.619 in settings where BCC is diagnosed or treated.
  • Align treatment plans with clinical guidelines for justified billing.
  • Include relevant CPT codes for surgical procedures.

ICD-10 Code C44.619 in Medical Billing and Insurance for Basal cell carcinoma skin/ left upper limb, inc shoulder

ICD-10 Code C44.619 is essential for accurate billing in hospital, ER, or outpatient settings.

Billing Notes:

  • Document all relevant clinical findings to support the diagnosis.
  • Use C44.619 in conjunction with procedure codes for surgical interventions.
  • Ensure compliance with payer-specific documentation requirements.

Common CPT Pairings:

CPT CodeDescription
11400Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 4.0 cm.
11600Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm.
99213Established patient office visit, low to moderate complexity.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C44.619 for Basal cell carcinoma skin/ left upper limb, inc shoulder

What are the common symptoms of basal cell carcinoma?

Common symptoms include a pearly or waxy bump, ulceration, and bleeding at the site. Patients may also report itching or tenderness.

How is basal cell carcinoma treated?

Treatment typically involves surgical excision of the tumor. Mohs micrographic surgery may be used for high-risk cases to ensure complete removal.

Is basal cell carcinoma contagious?

No, basal cell carcinoma is not contagious. It is primarily caused by UV exposure and is not transmitted between individuals.

How often should patients with basal cell carcinoma be monitored?

Patients should have regular follow-ups, typically every 6 to 12 months, to monitor for recurrence or new lesions.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved